Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | PKM | P14618 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18883512 | 0.87 | — | — | |
| SCHEMBL17577037 | 0.83 | GAA (0.37) | GAAPKMTDP1 | |
| SCHEMBL14213118 | 0.83 | GAA (0.37) | GAAPKMTDP1 | |
| SCHEMBL24213876 | 0.79 | APLNR (0.31) | — | |
| SCHEMBL21702859 | 0.79 | — | — | |
| SCHEMBL17415868 | 0.72 | — | — | |
| SCHEMBL11587542 | 0.71 | LMNA (0.50) | — | |
| SCHEMBL14014856 | 0.69 | LMNA (0.48) | — | |
| SCHEMBL1238743 | 0.69 | CYP2C9 (0.35) | — | |
| SCHEMBL16093367 | 0.69 | CYP2C9 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220021031-A1 | ELECTROLYTE ADDITIVE, ELECTROLYTE, LITHIUM ION SECONDARY BATTERY CONTAINING THE SAME AND USE THEREOF | MURATA MANUFACTURING CO., LTD. (JP) | 2022-01-20 | — | — | US | disclosed |
| US-9187442-B2 | Method for producing stereoselective epoxyketone compound | NISSAN CHEMICAL INDUSTIES, LTD. (JP) | 2015-11-17 | — | — | US | disclosed |
| US-20150126755-A1 | METHOD FOR PRODUCING STEREOSELECTIVE EPOXYKETONE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2015-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220021031-A1 | ELECTROLYTE ADDITIVE, ELECTROLYTE, LITHIUM ION SECONDARY BATTERY CONTAINING THE SAME AND USE THEREOF | HCN4, HCN2, SLC9B2 | GAA 3760/4885PKM 2222/4885TDP1 3254/4885 |
| US-20150126755-A1 | METHOD FOR PRODUCING STEREOSELECTIVE EPOXYKETONE COMPOUND | HSD17B7, CYP51A1, AKR1B10 | GAA 3502/4885PKM 770/4885TDP1 4552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.